Determinants of Endogenous Fibrinolysis in Whole Blood Under High Shear in Patients With Myocardial Infarction-Reference-Cited by-同舟云学术

Determinants of Endogenous Fibrinolysis in Whole Blood Under High Shear in Patients With Myocardial Infarction

Published:2022-11 Issue:11 Volume:7 Page:1069-1082
ISSN:2452-302X
Container-title:JACC: Basic to Translational Science
language:en
Short-container-title:JACC: Basic to Translational Science

Author:

Kanji Rahim,Gue Ying X.,Farag Mohamed F.^ORCID,Spencer Neil H.,Mutch Nicola J.,Gorog Diana A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference48 articles.

1. Impaired spontaneous/endogenous fibrinolytic status as new cardiovascular risk factor? JACC review topic of the week;Gorog;J Am Coll Cardiol,2019

2. Fibrinolysis in acute and chronic cardiovascular disease;Kietsiriroje;Semin Thromb Hemost,2021

3. Endogenous fibrinolysis: an important mediator of thrombus formation and cardiovascular risk;Okafor;J Am Coll Cardiol,2015

4. Biomarkers of coagulation and fibrinolysis in acute myocardial infarction: a joint position paper of the Association for Acute CardioVascular Care and the European Society of Cardiology Working Group on Thrombosis;Krychtiuk;Eur Hear J Acute Cardiovasc Care,2021

5. Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study;Farag;Eur Heart J,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of very low dose rivaroxaban in addition to dual antiplatelet therapy on endogenous fibrinolysis in acute coronary syndrome: The VaLiDate-R study;Thrombosis Research;2024-04

2. Ethnic Differences in Thrombotic Profiles of Acute Coronary Syndrome Patients and Relationship to Cardiovascular Outcomes: A Comparison of East Asian and White subjects;Thrombosis and Haemostasis;2023-12-29

3. Measuring Thrombus Stability at High Shear, Together With Thrombus Formation and Endogenous Fibrinolysis: First Experience Using the Global Thrombosis Test 3 (GTT-3);Clinical and Applied Thrombosis/Hemostasis;2023-01

4. Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1);Seminars in Thrombosis and Hemostasis;2022-12-15

5. “Going with the flow” in modeling fibrinolysis;Frontiers in Cardiovascular Medicine;2022-12-02